The Highly Potent Active Pharmaceutical Ingredients Conference will explore how the latest technologies can benefit HPAPI with artificial intelligence and machine learning to hasten risk assessment and validation. We will also be dedicating much deserved attention on emerging HPAPI therapies including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? Come and find the answers to these hot topics of HPAPI along with the other unique insights such as continuous HPAPI manufacturing technologies.
Attend this conference and join a networking platform for industry professionals to provide expertise to overcome the challenges of the HPAPI industry.